Redox vs Direct EHR Integration
Use Redox (or a similar integration platform) when you need to reach many health systems fast and don't want to build and maintain each connection yourself — it trades per-connection engineering for platform fees and one normalized API. Integrate directly when you have a small number of high-value EHR targets, need capabilities or data the platform doesn't expose, or when platform fees at your volume outweigh the engineering you'd save. Many teams start on a platform and selectively go direct for their biggest accounts.
Quick answer
Many systems, fast, minimal ops → Redox. Few high-value targets, deep needs, or fee-sensitive at scale → direct. Start on the platform, go direct where it pays.
Decision table at a glance
| Criterion | Redox | Direct |
|---|---|---|
| Time to first integration | Fast | Slower (build per connection) |
| Coverage / reach | Broad managed network | Only what you build |
| Cost model | Platform + usage fees | Engineering + maintenance |
| Control & data access | Normalized (some abstraction) | Full, raw access |
| Ops burden | Largely on the platform | On you |
| Best at scale | Many shallow connections | Few deep connections |
What they are
What is Redox
Redox is a healthcare integration platform that sits between your app and health systems, offering one normalized API (and a managed network of existing connections) instead of you building to each EHR. It handles a lot of the interface plumbing, monitoring, and connection management as a service.
What is Direct
Direct integration means building straight to each EHR's APIs (FHIR, proprietary) or interfaces (HL7 v2) yourself. You own every connection end to end — more engineering and maintenance, but full control of capabilities, data access, and cost per connection.
Key differences
Coverage and speed vs cost
A platform's core value is reach and velocity: you can say yes to a new health-system customer without a fresh multi-month interface project. That speed has a running cost — platform and usage fees that scale with connections and volume. Direct integration front-loads engineering but has no per-connection platform tax afterward.
Control and data fidelity
Normalization is a double-edged sword. One clean API is convenient, but abstraction can hide or reshape data you actually need, and platform capabilities lag the raw EHR APIs at the edges. Going direct gives you the full, unmediated data contract — essential when you need fields, write operations, or behaviors the platform doesn't surface.
Operational responsibility
With a platform, connection monitoring, health-system changes, and much of the interface upkeep are the vendor's problem. Direct means you own uptime, versioning, and every EHR's quirks. For a lean team, offloading that ops burden is often worth the fees; for a team with integration expertise and few targets, it's overhead you don't need.
Economics flip with your integration shape
The honest rule of thumb: many shallow connections favor a platform; a few deep, high-volume connections favor direct. Map your pipeline — breadth of health systems, depth per system, and transaction volume — against platform pricing to find where the lines cross.
When to use each
When to use Redox (Integration Platform)
- You need to connect to many health systems quickly across a sales pipeline.
- You want one API surface instead of maintaining N bespoke EHR interfaces.
- You'd rather pay platform fees than staff an interface/integration team.
- You value the platform's existing connections and reduced time-to-first-integration.
When to use Direct EHR Integration
- You have a small set of high-value EHR targets to integrate deeply.
- You need data or write capabilities the platform doesn't expose or normalizes away.
- Platform fees at your transaction/volume level exceed the cost of building direct.
- You require full control over latency, error handling, and the data contract.
Hybrid: platform for reach, direct for your biggest accounts
These aren't mutually exclusive. A common pattern is to use Redox to onboard the long tail of health systems quickly, while building direct integrations for your largest or most demanding accounts — where volume makes platform fees expensive or where you need capabilities the platform abstracts away.
Design your internal integration layer so the source (platform vs direct) is an implementation detail behind a stable domain model. That lets you move an account from platform to direct later without rewriting the app, and keeps your options open as economics and requirements evolve.
Frequently Asked Questions
Not sure which fits your build?
Tell us about your product, integration targets, and timeline. We'll map the trade-offs to your context and recommend the path that gets you to a compliant launch fastest.